From: The prognostic value of the nodal ratio in N1 breast cancer
Variable | No. of pts | 5-year LRRFS (%) | 5-year DMFS (%) | 5-year DFS (%) |
---|---|---|---|---|
Age | Â | Â | Â | Â |
≤40 | 31 | 92.7 | 84.3 | 84.3 |
> 40 | 99 | 96.8 | 96.2 | 93.7 |
 |  | p = 0.348 | p = 0.078 | p = 0.138 |
T stage | Â | Â | Â | Â |
T1 | 68 | 96.5 | 96.7 | 94.6 |
T2/3 | 62 | 95.0 | 89.5 | 87.7 |
 |  | p = 0.578 | p = 0.108 | p = 0.229 |
Nodal ratio | Â | Â | Â | Â |
≤0.15 | 100 | 97.9 | 96.4 | 94.0 |
> 0.15 | 30 | 88.7 | 81.3 | 81.3 |
 |  | p = 0.033 | p = 0.029 | p = 0.069 |
ER | Â | Â | Â | Â |
(-) | 28 | 96.4 | 96.4 | 95.4 |
(+) | 102 | 95.6 | 92.3 | 89.8 |
 |  | p = 0.895 | p = 0.462 | p = 0.374 |
PR | Â | Â | Â | Â |
(-) | 49 | 98.0 | 98.0 | 98.0 |
(+) | 81 | 94.5 | 90.5 | 87.5 |
 |  | p = 0.403 | p = 0.111 | p = 0.087 |
HER2 | Â | Â | Â | Â |
(-) or unknown | 107 | 94.4 | 92.0 | 89.7 |
(+) | 23 | 100.0 | 100.0 | 100.0 |
 |  | p = 0.421 | p = 0.180 | p = 0.163 |
Histologic grade | Â | Â | Â | Â |
G1/G2 | 85 | 97.3 | 94.3 | 92.7 |
G3 | 45 | 93.1 | 91.7 | 89.2 |
 |  | p = 0.203 | p = 0.354 | p = 0.510 |
ECE | Â | Â | Â | Â |
(-) or unknown | 97 | 95.5 | 91.3 | 90.2 |
(+) | 33 | 96.8 | 100.0 | 95.2 |
 |  | p = 0.639 | p = 0.117 | p = 0.332 |
LVI | Â | Â | Â | Â |
(-) or unknown | 67 | 96.4 | 95.0 | 93.3 |
(+) | 63 | 95.1 | 91.6 | 89.7 |
 |  | p = 0.639 | p = 0.927 | p = 0.768 |
RM | Â | Â | Â | Â |
(-) | 118 | 96.2 | 94.9 | 92.7 |
close or (+) | 12 | 91.7 | 83.3 | 83.3 |
 |  | p = 0.431 | p = 0.213 | p = 0.268 |
Surgery | Â | Â | Â | Â |
BCS | 67 | 98.5 | 95.5 | 95.5 |
MRM | 63 | 93.1 | 91.9 | 88.1 |
 |  | p = 0.160 | p = 0.556 | p = 0.345 |
Regional RT | Â | Â | Â | Â |
no | 115 | 96.2 | 93.3 | 91.2 |
yes | 15 | 93.3 | 93.3 | 93.3 |
 |  | p = 0.503 | p = 0.976 | p = 0.935 |
Chemotherapy | Â | Â | Â | Â |
no | 13 | 92.3 | 79.1 | 79.1 |
yes | 117 | 96.3 | 94.9 | 92.8 |
 |  | p = 0.401 | p = 0.104 | p = 0.173 |